Welcome to our dedicated page for Somnigroup International SEC filings (Ticker: SGI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Somnigroup International Inc. filings document regulatory disclosures for a NYSE-listed bedding company with common stock trading under SGI. Form 8-K reports cover operating and financial results, financial guidance, quarterly cash dividends, Regulation FD investor presentations, and other material-event disclosures tied to its omnichannel bedding platform.
Proxy materials describe board and shareholder voting matters, executive compensation, equity awards and governance practices. Company disclosures also identify business segments such as Mattress Firm, Tempur Sealy North America and Tempur Sealy International, along with capital-structure information for its common stock.
Somnigroup International Inc. filed its annual report describing a transformed business following the $5.1 billion Mattress Firm acquisition, funded with $3.1 billion in cash and about 34.2 million shares. The company now operates three segments, runs over 2,800 retail stores in more than 100 countries, and emphasizes omni‑channel distribution.
Somnigroup highlights industry-leading Tempur-Pedic, Sealy, Stearns & Foster and Mattress Firm brands, a heavier mix of direct-to-consumer sales, and a strategy focused on innovation, disciplined capital allocation and free cash flow. The filing details expanded leverage, supply-chain and inflation pressures, cybersecurity, environmental and data-privacy regulation, and broad sustainability and human-capital initiatives.
Somnigroup International Inc. furnished an updated investor presentation outlining its strategy as the world’s largest bedding company and providing detailed 2025 results and 2026–2028 targets. The business is vertically integrated across manufacturing, logistics and more than 2,800 retail stores, including Mattress Firm in the U.S. and Dreams in the UK.
For the quarter ended December 31, 2025, net sales were $1.87 billion, up 54.7% year over year, with net income of $140.8 million, up 95.8%. Full-year 2025 net sales reached $7.48 billion, up 51.6%, and adjusted EPS was $2.70.
The company expects 2026 sales of about $7.9 billion at the midpoint, adjusted EPS between $3.00 and $3.40, and adjusted EBITDA of $1.45 billion. Mattress Firm acquisition net synergies are targeted at $225 million of EBITDA impact by 2027, and adjusted EPS is targeted to grow to roughly $5.15 by 2028.
Leverage was 3.21x adjusted EBITDA per credit facility with about $774 million of liquidity as of December 31, 2025. Management plans to return roughly half of 2026 free cash flow to shareholders via dividends and share repurchases while maintaining a target leverage range of 2.0x to 3.0x.
Somnigroup International Inc. furnished an updated investor presentation outlining its strategy as the world’s largest bedding company and providing detailed 2025 results and 2026–2028 targets. The business is vertically integrated across manufacturing, logistics and more than 2,800 retail stores, including Mattress Firm in the U.S. and Dreams in the UK.
For the quarter ended December 31, 2025, net sales were $1.87 billion, up 54.7% year over year, with net income of $140.8 million, up 95.8%. Full-year 2025 net sales reached $7.48 billion, up 51.6%, and adjusted EPS was $2.70.
The company expects 2026 sales of about $7.9 billion at the midpoint, adjusted EPS between $3.00 and $3.40, and adjusted EBITDA of $1.45 billion. Mattress Firm acquisition net synergies are targeted at $225 million of EBITDA impact by 2027, and adjusted EPS is targeted to grow to roughly $5.15 by 2028.
Leverage was 3.21x adjusted EBITDA per credit facility with about $774 million of liquidity as of December 31, 2025. Management plans to return roughly half of 2026 free cash flow to shareholders via dividends and share repurchases while maintaining a target leverage range of 2.0x to 3.0x.
Select Equity Group, L.P. and George S. Loening filed Amendment No. 6 to report their ownership in Somnigroup International Inc. common stock. They report beneficial ownership of 10,429,043 shares, representing 4.97% of the company’s common stock, based on 209,907,662 shares outstanding as of November 4, 2025.
The filing shows no sole voting or dispositive power; all 10,429,043 shares are held with shared voting and shared dispositive power. The investors state the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Somnigroup.
Select Equity Group, L.P. and George S. Loening filed Amendment No. 6 to report their ownership in Somnigroup International Inc. common stock. They report beneficial ownership of 10,429,043 shares, representing 4.97% of the company’s common stock, based on 209,907,662 shares outstanding as of November 4, 2025.
The filing shows no sole voting or dispositive power; all 10,429,043 shares are held with shared voting and shared dispositive power. The investors state the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Somnigroup.
Somnigroup International reported a strong finish to 2025, with fourth quarter net sales of $1,868.4 million, up 54.7%, driven largely by the Mattress Firm acquisition. Quarterly EPS rose to $0.66, up 65.0%, while adjusted EPS increased 20.0% to $0.72.
For full year 2025, net sales grew to $7,476.5 million, up 51.6%. GAAP diluted EPS declined to $1.84 from $2.16, but adjusted EPS rose to $2.70, a 5.9% increase. Management highlighted record fourth quarter net sales and adjusted EBITDA, and meaningful margin gains in North America.
The company ended 2025 with consolidated indebtedness less netted cash of $4.6 billion, a leverage ratio of 3.21 times adjusted EBITDA per its credit facility. Somnigroup guided 2026 adjusted EPS to $3.00–$3.40 and internally targets adjusted EPS of about $5.15 by 2028. The Board raised the quarterly dividend 13% to $0.17 per share.
Somnigroup International reported a strong finish to 2025, with fourth quarter net sales of $1,868.4 million, up 54.7%, driven largely by the Mattress Firm acquisition. Quarterly EPS rose to $0.66, up 65.0%, while adjusted EPS increased 20.0% to $0.72.
For full year 2025, net sales grew to $7,476.5 million, up 51.6%. GAAP diluted EPS declined to $1.84 from $2.16, but adjusted EPS rose to $2.70, a 5.9% increase. Management highlighted record fourth quarter net sales and adjusted EBITDA, and meaningful margin gains in North America.
The company ended 2025 with consolidated indebtedness less netted cash of $4.6 billion, a leverage ratio of 3.21 times adjusted EBITDA per its credit facility. Somnigroup guided 2026 adjusted EPS to $3.00–$3.40 and internally targets adjusted EPS of about $5.15 by 2028. The Board raised the quarterly dividend 13% to $0.17 per share.
Somnigroup International Inc. filed a current report to let investors know it has issued a press release about ongoing discussions with Leggett & Platt. The company furnished this press release as Exhibit 99.1 under a Regulation FD disclosure item, which is used to share material information broadly with the market.
The company notes that the information in this section, including the press release, is being furnished rather than filed, meaning it is not subject to certain Exchange Act liabilities and will only be incorporated into other SEC documents if specifically referenced. The filing is signed by Executive Vice President and Chief Financial Officer Bhaskar Rao, underscoring management’s authorization of the disclosure.
SomniGroup International Inc. president and CEO reports multiple equity transactions on January 2, 2026. The Form 4 shows several blocks of common stock acquired at $0 per share under vested restricted stock units and performance restricted stock units, followed by share disposals at $88.74 per share to cover tax withholding. After these transactions, the reporting person directly beneficially owns 295,869 shares of SomniGroup common stock and indirectly owns 22,400 shares through a family limited liability company.
In the derivative table, previously granted RSUs and performance RSUs convert into common stock on a one-for-one basis as they vest under awards originally granted between 2022 and 2025. The filing also discloses a new grant on January 2, 2026 of 14,086 restricted stock units, scheduled to vest in four annual installments on January 4 of 2027, 2028, 2029 and 2030.
Somnigroup International Inc.'s CEO of Tempur Sealy reported multiple equity transactions on January 2, 2026. Several blocks of common stock were acquired at $0 through the vesting and conversion of restricted stock units and performance restricted stock units, and portions of these shares were disposed of at $88.74 per share, typically to cover related obligations.
After these transactions, the CEO directly owned 248,334 shares of Somnigroup common stock and indirectly held 286,679 shares through the Buster Family Trust. The filing also shows a new grant of 14,086 restricted stock units, which are scheduled to vest in four annual installments on January 4, 2027, 2028, 2029 and 2030. Performance awards referenced in the filing are based on metrics such as adjusted EBITDA, adjusted EPS, relative TSR percentile and qualitative ESG or strategic initiatives performance.
Somnigroup International Inc. EVP Global Business Strategy reported multiple equity award transactions in company common stock on January 2, 2026. A series of restricted stock units and performance restricted stock units were exercised (transaction code M) and converted into common shares at an exercise price of $0, while shares were simultaneously withheld (transaction code F) at $88.74 per share, primarily to cover tax obligations. Following these transactions, the reporting person beneficially owned 858,570 shares of Somnigroup International common stock directly.
In addition, the executive received a new grant of 5,635 restricted stock units, which vest in four annual installments on January 4 of 2027, 2028, 2029 and 2030. The explanations note that all restricted and performance stock units convert into common stock on a one-for-one basis and describe prior grants that vest over several years, linking vesting and payouts to metrics such as adjusted EBITDA, adjusted EPS, relative TSR percentile and qualitative ESG and strategic performance.
Somnigroup International Inc. EVP & Chief Financial Officer Bhaskar Rao reported multiple equity transactions on January 2, 2026. Several restricted stock units and performance restricted stock units were converted into common stock on a one-for-one basis at an exercise price of $0, followed by sales of shares at $88.74 to cover obligations.
After the reported transactions, Rao directly beneficially owned 354,036 shares of Somnigroup common stock. In addition, he received a new grant of 11,269 restricted stock units on January 2, 2026, scheduled to vest in four annual installments on January 4, 2027, 2028, 2029 and 2030. Earlier grants from 2022 through 2025 include time-based RSUs and performance shares tied to adjusted EBITDA, adjusted EPS, relative TSR percentile and qualitative ESG or strategic initiatives performance.
Somnigroup International Inc. CEO, President and Director reported several equity transactions on January 2, 2026. He exercised 71,762 restricted stock units and 100,748 performance restricted stock units into common stock at an exercise price of $0, reflecting previously granted awards that vested. To cover taxes, he disposed of 28,239 shares and 39,726 shares of common stock at a price of $88.74 per share. After these transactions, he directly owned 4,093,634 shares of common stock. He also received a new grant of 56,345 restricted stock units, which are scheduled to vest in full on January 4, 2027.